American Bio Medica (American Bio Medica) Debt-to-Equity

: -0.38 (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

American Bio Medica's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.18 Mil. American Bio Medica's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.00 Mil. American Bio Medica's Total Stockholders Equity for the quarter that ended in Mar. 2023 was $-0.46 Mil. American Bio Medica's debt to equity for the quarter that ended in Mar. 2023 was -0.38.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for American Bio Medica's Debt-to-Equity or its related term are showing as below:

ABMC's Debt-to-Equity is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 0.24
* Ranked among companies with meaningful Debt-to-Equity only.

American Bio Medica Debt-to-Equity Historical Data

The historical data trend for American Bio Medica's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Bio Medica Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

-10.51

-2.02

-1.50

-1.68

-0.96

American Bio Medica Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Debt-to-Equity																-1.14	-0.90	-0.80	-0.96	-0.38

Competitive Comparison

For the Diagnostics & Research subindustry, American Bio Medica's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Bio Medica Debt-to-Equity Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, American Bio Medica's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where American Bio Medica's Debt-to-Equity falls into.

American Bio Medica Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

American Bio Medica's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.234	+	0.006)	/	-2.339
	=	-0.96

American Bio Medica's Debt to Equity Ratio for the quarter that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.175	+	0)	/	-0.458
	=	-0.38

American Bio Medica (OTCPK:ABMC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

American Bio Medica Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of American Bio Medica's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

American Bio Medica (American Bio Medica) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » American Bio Medica Corp (OTCPK:ABMC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

122 Smith Road, Kinderhook, New York, NY, USA, 12106

Website

https://www.abmc.com

American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.

Executives

Stuart Steinberg	10 percent owner	85 BELLEVUE AVENUE, RYE NY 10580
John J Moroney	10 percent owner	118 PEGASUS DR., JUPITER FL 33477
Chaim Davis	director	2601 PINE TREE DRIVE, MIAMI BEACH FL 33140
Peter Jerome	director	7 RIDGECREST AVE, LATHAM NY 12110
Diane Generous	director	122 SMITH ROAD, KINDERHOOK NY 12106
Melissa A Waterhouse	officer: EVP, CCO, CORP SEC	AMERICAN BIO MEDICA CORPORATION, 122 SMITH ROAD, KINDERHOOK NY 12106
Mp Biomedicals Llc	10 percent owner	3 HUTTON CENTRE DRIVE, SUITE 100, SANTA ANA CA 92707
Douglas Casterlin	officer: Executive Vice President	C/O MELISSA A. WATERHOUSE/ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106
Jean Neff	director	C/O ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106
Stefan Parker	officer: Chief Financial Officer	122 SMITH ROAD, KINDERHOOK NY 12106
Carl A Florio	director	C/O HUDSON RIVER BANK & TRUST CO, PO BOX 76, HUDSON NY 12534
Stan Cipkowski	director	300 S LAKE DR, STE 340, FISHKILL NY 12553
Anthony G Costantino	director	122 SMITH ROAD, KINDERHOOK NY 12106
Edmund M Jaskiewicz	director, officer: President
Richard Koskey	director	C/O ABMC 122 SMITH ROAD, 122 SMITH ROAD, KINDERHOOK NY 12106